Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -342,994 | -234,632 | -183,118 | -250,219 | -204,472 |
| Depreciation Amortization | 4,950 | 10,654 | 17,090 | 15,525 | 4,833 |
| Accounts payable and accrued liabilities | -3,234 | 1,464 | 667 | 91 | -278 |
| Other Working Capital | -3,120 | 3,421 | -82,015 | 4,015 | -336 |
| Other Operating Activity | 182,004 | 55,399 | 77,821 | 104,339 | 39,379 |
| Operating Cash Flow | $-162,394 | $-163,694 | $-169,555 | $-126,249 | $-160,874 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 154,234 | 186,734 | 12,736 | -56,069 | -222,035 |
| PPE Investments | -31,810 | -2,686 | -24,276 | -65,504 | -51,481 |
| Investing Cash Flow | $122,424 | $184,048 | $-11,540 | $-121,573 | $-273,516 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,402 | 2,200 | 11,096 | 401,244 | 373 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -11,806 |
| Other Financing Activity | -76 | -457 | -461 | 0 | 488,223 |
| Financing Cash Flow | $1,326 | $1,743 | $10,635 | $401,244 | $476,790 |
| Beginning Cash Position | 145,931 | 123,834 | 294,294 | 140,872 | 98,472 |
| End Cash Position | 107,287 | 145,931 | 123,834 | 294,294 | 140,872 |
| Net Cash Flow | $-38,644 | $22,097 | $-170,460 | $153,422 | $42,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162,394 | -163,694 | -169,555 | -126,249 | -160,874 |
| Capital Expenditure | -31,810 | -2,686 | -24,276 | -65,504 | -51,481 |
| Free Cash Flow | -194,204 | -166,380 | -193,831 | -191,753 | -212,355 |